5328152026-01-012026-03-315328152026-03-315328152026-01-012026-03-31CompositionOfBoardOfDirectors15328152026-03-31CompositionOfBoardOfDirectors15328152026-01-012026-03-31CompositionOfBoardOfDirectors25328152026-03-31CompositionOfBoardOfDirectors25328152026-01-012026-03-31CompositionOfBoardOfDirectors35328152026-03-31CompositionOfBoardOfDirectors35328152026-01-012026-03-31CompositionOfBoardOfDirectors45328152026-03-31CompositionOfBoardOfDirectors45328152026-01-012026-03-31CompositionOfBoardOfDirectors55328152026-03-31CompositionOfBoardOfDirectors55328152026-01-012026-03-31CompositionOfBoardOfDirectors65328152026-03-31CompositionOfBoardOfDirectors65328152026-01-012026-03-31CompositionOfBoardOfDirectors75328152026-03-31CompositionOfBoardOfDirectors75328152026-01-012026-03-31CompositionOfBoardOfDirectors85328152026-03-31CompositionOfBoardOfDirectors85328152026-01-012026-03-31CompositionOfCommittees145328152026-03-31CompositionOfCommittees145328152026-01-012026-03-31CompositionOfCommittees155328152026-03-31CompositionOfCommittees155328152026-01-012026-03-31CompositionOfCommittees165328152026-03-31CompositionOfCommittees165328152026-01-012026-03-31CompositionOfCommittees175328152026-03-31CompositionOfCommittees175328152026-01-012026-03-31CompositionOfCommittees415328152026-03-31CompositionOfCommittees415328152026-01-012026-03-31CompositionOfCommittees425328152026-03-31CompositionOfCommittees425328152026-01-012026-03-31CompositionOfCommittees435328152026-03-31CompositionOfCommittees435328152026-01-012026-03-31CompositionOfCommittees685328152026-03-31CompositionOfCommittees685328152026-01-012026-03-31CompositionOfCommittees695328152026-03-31CompositionOfCommittees695328152026-01-012026-03-31CompositionOfCommittees705328152026-03-31CompositionOfCommittees705328152026-01-012026-03-31CompositionOfCommittees715328152026-03-31CompositionOfCommittees715328152026-01-012026-03-31CompositionOfCommittees955328152026-03-31CompositionOfCommittees955328152026-01-012026-03-31CompositionOfCommittees965328152026-03-31CompositionOfCommittees965328152026-01-012026-03-31CompositionOfCommittees975328152026-03-31CompositionOfCommittees975328152026-01-012026-03-31CompositionOfCommittees1225328152026-03-31CompositionOfCommittees1225328152026-01-012026-03-31CompositionOfCommittees1235328152026-03-31CompositionOfCommittees1235328152026-01-012026-03-31CompositionOfCommittees1245328152026-03-31CompositionOfCommittees1245328152026-03-31MeetingOfBoardOfDirectors15328152026-01-012026-03-31MeetingOfBoardOfDirectors15328152026-03-31MeetingOfBoardOfDirectors25328152026-01-012026-03-31MeetingOfBoardOfDirectors25328152026-03-31MeetingOfBoardOfDirectors35328152026-01-012026-03-31MeetingOfBoardOfDirectors35328152026-01-012026-03-31MeetingOfCommittees15328152026-03-31MeetingOfCommittees15328152026-01-012026-03-31MeetingOfCommittees25328152026-03-31MeetingOfCommittees25328152026-01-012026-03-31MeetingOfCommittees35328152026-03-31MeetingOfCommittees35328152026-01-012026-03-31MeetingOfCommittees45328152026-03-31MeetingOfCommittees45328152026-01-012026-03-31MeetingOfCommittees55328152026-03-31MeetingOfCommittees55328152026-01-012026-03-31MeetingOfCommittees65328152026-03-31MeetingOfCommittees65328152026-01-012026-03-31MeetingOfCommittees75328152026-03-31MeetingOfCommittees75328152025-12-315328152026-03-31OngoingTaxLitigationsOrDisputesDomain15328152026-03-31OngoingTaxLitigationsOrDisputesDomain2xbrli:pure532815SMSPHARMANOTLISTEDINE812G01025SMS PHARMACEUTICALS LIMITED2025-04-012026-03-31Yearly2026-03-31EquitytruetruefalseNo Acquisition during the quarterfalseNot ApplicabletruefalseNo such loans/Guarantees/Comfort Letter/Securities during the quartertrueTop 2000 listed entitiestrues00403OriginaltruetrueMrRamesh Babu Potluri******00166381Executive DirectorChairpersonMD1959-06-23falseActiveNA1990-08-302021-10-0101000MrShravan Kudaravalli******06905851Non-Executive - Independent DirectorNot Applicable1978-04-28falseActiveNA2018-09-202023-05-26341111MrSarvepalli Srinivas******02292051Non-Executive - Independent DirectorNot Applicable1962-06-29falseActiveNA2019-08-122024-08-12191110MrVamsi Krishna Potluri******06956498Executive DirectorNot Applicable1988-08-15falseActiveNA2020-06-052025-07-0101010MrTrilok Potluri******07634613Non-Executive - Non Independent DirectorNot Applicable1989-12-27falseActiveNA2024-08-1201010MrSunkara Venkata Satya Shiva Prasad******10404277Non-Executive - Non Independent DirectorNot Applicable1961-09-15falseActiveNA2024-08-1202121MrSuresh Kumar Gangavarapu******00183128Non-Executive - Independent DirectorNot Applicable1951-01-22falseActiveYes2024-09-302024-08-1219.21110MrsShanti Sree Bolleni******07092258Non-Executive - Independent DirectorNot Applicable1962-05-17falseActiveNA2024-08-1219.25591truetruetruetruetrueAudit Committee06905851Shravan KudaravalliNon-Executive - Independent DirectorChairperson2018-05-26Audit Committee00183128Suresh Kumar GangavarapuNon-Executive - Independent DirectorMember2024-08-12Audit Committee06956498Vamsi Krishna PotluriExecutive DirectorMember2024-08-12Audit Committee07092258Shanti Sree BolleniNon-Executive - Independent DirectorMember2025-05-30Nomination and remuneration committee07092258Shanti Sree BolleniNon-Executive - Independent DirectorChairperson2024-08-12Nomination and remuneration committee00183128Suresh Kumar GangavarapuNon-Executive - Independent DirectorMember2024-08-12Nomination and remuneration committee10404277Sunkara Venkata Satya Shiva PrasadNon-Executive - Non Independent DirectorMember2024-08-12Stakeholders Relationship Committee10404277Sunkara Venkata Satya Shiva PrasadNon-Executive - Non Independent DirectorChairperson2024-08-12Stakeholders Relationship Committee07634613Trilok PotluriNon-Executive - Non Independent DirectorMember2024-08-12Stakeholders Relationship Committee02292051Sarvepalli SrinivasNon-Executive - Independent DirectorMember2019-08-12Stakeholders Relationship Committee07092258Shanti Sree BolleniNon-Executive - Independent DirectorMember2024-08-12Risk Management Committee00166381Ramesh Babu PotluriExecutive DirectorChairperson2021-05-28Risk Management Committee06956498Vamsi Krishna PotluriExecutive DirectorMember2021-05-28Risk Management Committee06905851Shravan KudaravalliNon-Executive - Independent DirectorMember2021-05-28Corporate Social Responsibility Committee00166381Ramesh Babu PotluriExecutive DirectorChairperson2008-12-01Corporate Social Responsibility Committee06905851Shravan KudaravalliNon-Executive - Independent DirectorMember2019-08-12Corporate Social Responsibility Committee02292051Sarvepalli SrinivasNon-Executive - Independent DirectorMember2019-08-122025-10-16true8642025-11-0822true8742026-02-0790true884During the quarter one Independent Directors Meeting held on 07.02.2026Audit Committee2025-10-16true4330Audit Committee2025-11-0721true4430Audit Committee2026-02-0690true4430Stakeholders Relationship Committee2025-11-08true4320Stakeholders Relationship Committee2026-02-07true4420Risk Management Committee2026-02-06true3310Corporate Social Responsibility Committee2026-02-07true3320truetruetruetrueYestruetruetrueRamesh Babu PotluriManaging DirectorYeshttps://smspharma.com/who-we-are/Yeshttps://smspharma.com/company-announcements/downloads/Yeshttps://smspharma.com/corporate-governance/management-team-information/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/corporate-governance/management-team-information/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/investors-contact/Yeshttps://smspharma.com/investors-contact/Yeshttps://smspharma.com/financials/quarterly-financial-results/Yeshttps://smspharma.com/investor-information/shareholding/NAYeshttps://smspharma.com/financials/quarterly-financial-results/Yeshttps://smspharma.com/financials/audio-or-video-recording-of-investors-meet/NAYeshttps://smspharma.com/company-announcements/news-paper-publication/Yeshttps://smspharma.com/company-announcements/corporate-announcements/Yeshttps://smspharma.com/annual-report/Yeshttps://smspharma.com/company-announcements/corporate-announcements/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/investors/Yeshttps://smspharma.com/company-announcements/corporate-announcements/Yeshttps://smspharma.com/corporate-governance/governance-documents-policies/Yeshttps://smspharma.com/annual-report/NAYeshttps://smspharma.com/disclosures-under-regulation-46-of-the-lodr/Yeshttps://smspharma.com/disclosures-under-regulation-46-of-the-lodr/YesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesNAYesNAYesYesYesYesYesYesYesYesYesYesNAYesRamesh Babu PotluriManaging DirectorYesRamesh Babu PotluriManaging DirectorfalseRamesh Babu PotluriManaging DirectorHyderabad2026-04-1700000Faceless Assessment Unit, Income Tax Department2025-03-23The Company received an assessment order dated 22nd March, 2025 under Section 144 read with Section 144B of the Income Tax Act, 1961 for AY 2023-24, raising a demand of Rs. 45.63 Crores (including interest) along with penalty proceedings. The Company has filed an appeal before the Commissioner of Income Tax (Appeals), National Faceless Appeal Centre and a grievance before the High-Pitched Assessment Committee. Stay petitions have also been filed before the Assessing Officer and the Principal Commissioner of Income Tax, Hyderabad. The Company has duly responded to all notices, including penalty-related communications, and submitted requisite information within prescribed timelines. Further, the Company received subsequent communications regarding outstanding demand, to which replies were filed stating that the matter is sub judice. The Company has also filed detailed submissions, supporting documents, and an additional evidence petition under Rule 46A in response to notices issued by the appellate authority. During the quarter, the company received a notice dated 30.01.2026 from DCIT, Hyderabad stating that to submit justification in support of admission before CIT(A) along with necessary documentary evidence. The company has submitted information. Subsequently, the company has received a notice dated 25.02.2026 from the Commissioner of Income Tax (Appeals), NFAC stating that to offer our comments on Remand Report. The company has submitted a rejoinder to the remand report. Faceless Assessment Unit, Income Tax Department2026-03-31The Company has received an assessment order under Section 147 read with section 144B of the Income Tax Act, 1961 for Assessment Year 2018-19, by addition of income and disallowance of deduction u/s 35 of the Act., and Income Tax demand notice dated 30th March 2026, received on 31st March 2026. under Section 156 of the Income Tax Act, 1961, raised a demand of Rs.7.19 crores for the Assessment Year 2018-19. Further, penalty proceedings u/s 270A is initiated separately for under reporting of income.Same Status